Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
December 6, 2025
 · 
Reactions
MyMyelomaTeam

What are the long-term side effects of ixazomib after taking it for about 4 years, and are there alternative drug families that could replace it for IgG myeloma?

Ixazomib (Ninlaro) is a proteasome inhibitor that has been shown to help lengthen progression-free survival, even in high-risk cases, when taken long-term Show Full Answer

What are the long-term side effects of ixazomib after taking it for about 4 years, and are there alternative drug families that could replace it for IgG myeloma?

Ixazomib (Ninlaro) is a proteasome inhibitor that has been shown to help lengthen progression-free survival, even in high-risk cases, when taken long-term. However, extended use can lead to side effects.

Commonly reported side effects of ixazomib include:
* Nausea and vomiting
* Fatigue
* Fever
* Low white blood cell counts
* Diarrhea
* Constipation
* Back pain
* Easy bruising or bleeding

While this information covers general side effects, individual experiences with long-term use can vary. A MyMyelomaTeam member taking ixazomib for 4 years might experience different or additional effects that should be discussed with their healthcare team.

Regarding alternatives to proteasome inhibitors like ixazomib, other drug families used for myeloma include:
* Immunomodulators (lenalidomide, pomalidomide, thalidomide)
* Monoclonal antibodies (daratumumab, isatuximab, elotuzumab)
* Bispecific antibodies
* CAR T-cell therapies

Your myeloma specialist can help determine if switching to a different drug family makes sense based on your specific situation, treatment history, and how well ixazomib is controlling your disease. They'll weigh the benefits against potential risks of any new therapy.

December 6, 2025

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Maine USA